Healthcare Innovation February 4, 2025
Expert notes that insurance coverage remains poor for obesity as a medical condition
President Trump’s nomination of Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS) has generated buzz across the healthcare industry. When it comes to obesity treatment, Medicare and Medicaid only cover Ozempic for diabetes treatment – not for off-label use like obesity. With obesity care coverage limited, and with Robert F. Kennedy Jr. (RFK), a known opposer to Ozempic and obesity treatments beyond lifestyle changes, to become Secretary of Health and Human Services (HHS), the future of accessible obesity care is unknown.
Brooke Boyarsky Pratt, CEO and co-founder of knownwell, a primary care company specializing in obesity, recently spoke with Healthcare Innovation...
Today's Sponsors
Today's Sponsor